You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’

Citation Tools

Article menu
Correspondence
Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ramirez GA, Della-Torre E, Moroni L On behalf of the OSR-COVAX study group, et al
Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Annals of the Rheumatic Diseases 2021;80:e159.